Despite the heterogeneity of these studies and absence of investigations including TBSCC, increased infiltration by CD8+ T cells is the only immune cell type in head and neck SCC consistently proven to be correlated with increased survival regardless of tumor location, stage, and/or treatment [60]. Here, CD8A is linked to neoplasm.